FDA approves first nasal Nalmefene spray for opioid overdoseTherapeuticsIndivior’s Opvee is an emergency nasal spray medication to reverse opioid overdose approved for patients aged 12 years and above with signs of respiratory or central nervous system depression. Read more May 23, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/05/US-Bridging-Study-Not-Enough-as-FDA-Denies-Hutchmeds-Pancreatic-Cancer-Drug-BioSpace-5-2-22.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-05-23 09:03:592023-05-23 09:03:59FDA approves first nasal Nalmefene spray for opioid overdose
